Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma

Kotaro Miyao, Reona Sakemura, Kanae Imai, Toshiyasu Sakai, Natsuko Tsushita, Tomonori Kato, Keiko Niimi, Yoshitaka Ono, Masashi Sawa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences